16 Oct 2026

PBAC Publishes Outcomes From September 2026 Intracycle Meeting

PBAC Publishes Outcomes From September 2026 Intracycle Meeting

12 Oct 2026

PBAC updates guidance on broad cancer medicine listings

Australia’s Pharmaceutical Benefits Advisory Committee (PBAC) has updated its guidance for companies seeking broader listings of certain cancer medicines, following discussions at its September 2026 meeting.

08 Oct 2026

Webinar to Discuss Affordable Access to Medicines in Australia

The Australian Government Department of Health, Disability and Ageing will host a webinar on 23 October 2026, from 2 pm to 3 pm AEDT, for patient groups and other interested stakeholders.

01 Oct 2026

PBS Updates Diltiazem Capsule Substitution Rules During Shortage

The Australian Department of Health, Disability and Ageing has updated the rules for pharmacists supplying diltiazem hydrochloride capsules during a medicine shortage.

01 Oct 2026

PBS Website Updated with Changes Effective 1 October 2026

The Australian Government’s Pharmaceutical Benefits Scheme (PBS) website has been updated for 1 October 2026.

22 Sep 2026

Applications Open for Health Technology Assessment Reform Group

Applications Open for Health Technology Assessment Reform Group

15 Sep 2026

PBAC Publishes May 2026 Meeting Summaries

PBAC Publishes May 2026 Meeting Summaries

09 Sep 2026

PBAC Releases Update on Zoladex Implant Listing

PBAC Releases Update on Zoladex Implant Listing

04 Sep 2026

November 2026 PBAC meeting agenda updated

November 2026 PBAC meeting agenda updated

01 Sep 2026

PBS expands access to hepatitis B and C medicines

More health practitioners can now prescribe PBS-subsidised medicines for hepatitis B and hepatitis C, following changes to the Pharmaceutical Benefits Scheme (PBS) Highly Specialised Drugs (HSD) Program.